Sickle Cell Screen

Sample type: Whole Blood
Negativ
A negative result in a sickle cell screen typically means that the individual being tested does not carry two copies of the abnormal hemoglobin gene mutations associated with sickle cell disease (SCD). In other words, they do not have sickle cell disease itself. Instead, they may have one or two normal hemoglobin genes (HbA/HbA) or one normal hemoglobin gene and one copy of an abnormal hemoglobin gene (e.g., HbS or HbC). It's important to note that a negative result in a sickle cell screen only rules out the presence of sickle cell disease (SCD). It does not provide information about other hemoglobinopathies or genetic conditions that may affect hemoglobin. Additionally, if both parents are carriers of an abnormal hemoglobin gene (e.g., HbS or HbC), there is still a risk of having a child with SCD or sickle cell trait.

A sickle cell screen, also known as a sickle cell test or sickle cell screening, is a medical test used to determine whether an individual carries a gene mutation associated with sickle cell disease (SCD). Sickle cell disease is a genetic disorder that affects the shape of red blood cells, causing them to become rigid and assume a characteristic "sickle" shape. These misshapen red blood cells can lead to various health problems, including pain, anemia, and organ damage.

The sickle cell screen typically involves a blood test to detect the presence of abnormal hemoglobin, the protein responsible for carrying oxygen in red blood cells.

The two most common types of abnormal hemoglobin associated with sickle cell disease are:

  1. Hemoglobin S (HbS): This is the abnormal hemoglobin found in individuals with sickle cell disease. People who inherit one copy of the HbS gene and one normal hemoglobin gene (HbA) are considered carriers or have sickle cell trait. They may not have symptoms of the disease but can pass the gene on to their offspring.

  2. Hemoglobin C (HbC): Hemoglobin C is another abnormal hemoglobin variant that can be detected through screening. Individuals with one copy of the HbC gene and one normal hemoglobin gene (HbA) may have a condition called hemoglobin C trait.

The sickle cell screen is often performed as part of newborn screening programs, especially in regions where sickle cell disease is more common, such as parts of Africa, the Mediterranean, the Middle East, and certain areas in the Americas. Early detection through screening allows for timely intervention and management to prevent or mitigate the complications associated with sickle cell disease.

In addition to newborn screening, sickle cell screening may also be recommended for individuals who are planning to have children, as knowing their carrier status can help assess the risk of passing the disease to their offspring. It can also be offered to individuals from populations with a higher prevalence of sickle cell disease.

It's important to note that a sickle cell screen does not diagnose sickle cell disease itself but rather identifies carriers of the gene mutations associated with the condition. Further tests, such as hemoglobin electrophoresis or genetic testing, may be required to confirm the diagnosis of sickle cell disease or trait in individuals who screen positive.

Sickle Cell Screen
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Sickle Cell Screen — 10,000+ markers explained
One Sickle Cell Screen result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro